profit from every $100 of sales.
$0$100
The Pennant Group
$36.07+0.45% today
+44.9% in 1 year
1-year low $24.891-year high $44.04
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $42.84 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What The Pennant Group sold, what it kept, and what it did with the cash.
Sales went from $473 million in 2022 to $948 million in 2025, with $29.6 million of profit last year.
SalesProfit
The Pennant Group vs. similar companies
The Pennant Group grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| The Pennant Group | 42.8× · Expensive | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
AI analysis
An AI analyst reads The Pennant Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 473 | 545 | 695 | 948 | |
| 59 | 67 | 94 | 131 | |
| 20 | 25 | 37 | 51 | |
| 18 | 31 | 44 | 61 | |
| 7 | 13 | 23 | 30 | |
| 0.22 | 0.44 | 0.70 | 0.84 | |
| 12.4% | 12.3% | 13.5% | 13.8% | |
| 4.2% | 4.6% | 5.4% | 5.4% | |
| 1.4% | 2.5% | 3.2% | 3.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 512 | 540 | 680 | 968 |
| Cash | 2 | 6 | 24 | 17 |
| Total debt | 327 | 330 | 273 | 453 |
| Total liabilities | 386 | 394 | 368 | 594 |
| 121 | 140 | 293 | 333 | |
| 30 | 30 | 32 | 35 | |
| 2.2% | 4.3% | 5.3% | 5.3% | |
| 5.5% | 9.5% | 7.7% | 8.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9 | 33 | 39 | 48 | |
| 14 | 8 | 9 | 12 | |
| -5 | 25 | 30 | 36 | |
| Dividends paid | – | – | – | – |
| 0 | – | – | – | |
| 3 | 5 | 8 | 9 |
Valuation
- 42.8×
- 27.2×
- 0.76
- 3.4×
- 1.3×
- 35.0×
- 28.0×
- 2.9%
- 2.3%
- 0.0%
Profitability
- 13.8%
- 5.4%
- 3.1%
- 6.6%
- 5.0%
- 2.5%
- 9.2%
- 3.2%
- 7.0%
- –
Growth
- +26.0%
- +56.3%
- −13.2%
- –
- +5.0%
Financial health
- 6.6×
- 1.29
- 46.7%
- 24.1×
- 1.19
- 1.19
- 1.07
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 47%of 952
Bottom 37%of 884
Bottom 29%of 601
Top 21%of 886
Top 36%of 987
What analysts expect
- Average price target
- $39.00
- Range
- $38.00 – $40.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 0.32 | 0.31 | +3.2% |
| Feb 25, 2026 | 0.34 | 0.31 | +9.7% |
| Nov 5, 2025 | 0.30 | 0.29 | +3.4% |
| Aug 6, 2025 | 0.27 | 0.26 | +3.8% |
| May 6, 2025 | 0.27 | 0.22 | +22.7% |
| Feb 27, 2025 | 0.24 | 0.24 | +0.0% |
| Nov 6, 2024 | 0.26 | 0.23 | +13.0% |
| Aug 6, 2024 | 0.24 | 0.22 | +9.1% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
29No pass
Philip Fisher
39No pass
Peter Lynch
85Pass
Joel Greenblatt
3No pass
Charlie Munger
11No pass
Terry Smith
22No pass
Questions about The Pennant Group
Is The Pennant Group a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the The Pennant Group AI analysis
What does The Pennant Group do?
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. It is in Medical - Care Facilities.
Does The Pennant Group pay a dividend?
No. The Pennant Group does not pay a dividend at the moment.
Is The Pennant Group stock halal?
No. The Pennant Group does not pass our halal screen: its debt is 36% of its market value, at or above the 33% limit. How we check
How has The Pennant Group stock done over the past year?
Up 44.9% over the past twelve months, to $36.07. It traded between $24.89 and $44.04 and is 18.1% below its high.
Who are The Pennant Group's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with The Pennant Group's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.